Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula (right eye)
ICD-10 E09.3521 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula (right eye).
E09.3521 refers to diabetes mellitus that is induced by drugs or chemicals, which can lead to various complications, including proliferative diabetic retinopathy. This specific code indicates that the patient has developed traction retinal detachment involving the macula in the right eye due to the effects of diabetes. Proliferative diabetic retinopathy is characterized by the growth of new blood vessels in the retina, which can lead to severe vision impairment or loss. The presence of traction retinal detachment indicates that these new vessels have caused the retina to pull away from the underlying tissue, particularly affecting the macula, the area responsible for sharp central vision. Management of this condition often involves controlling blood glucose levels, monitoring HbA1c levels, and potentially surgical intervention to address the retinal detachment. Insulin management may be necessary to stabilize blood sugar levels, especially in cases where the diabetes is drug-induced.
Detailed retinal examination findings, including imaging results and visual acuity assessments.
Patients presenting with vision changes due to diabetic retinopathy or retinal detachment.
Ensure documentation specifies the eye affected and the type of retinal detachment.
Comprehensive diabetes management records, including medication history and HbA1c levels.
Patients with drug-induced diabetes requiring insulin therapy and monitoring.
Document the specific drugs causing diabetes and their effects on blood glucose control.
Used for treating proliferative diabetic retinopathy.
Document the extent of retinopathy and treatment rationale.
Ophthalmology should provide detailed notes on the procedure and patient response.
Specifying the eye affected is crucial for treatment planning and understanding the severity of the condition, as it directly impacts the patient's vision and management strategies.
